{"pmid":32414708,"title":"Airway management considerations in patients with COVID-19.","text":["Airway management considerations in patients with COVID-19.","Approximately 12% to 15% of hospitalized patients with COVID-19 infection require invasive ventilation via endotracheal intubation. The key to minimizing risk of disease transmission during this aerosol-generating procedure is careful preparation, which includes having necessary equipment and medications on hand as well as an experienced intubation team who can troubleshoot any unforeseen complications. Personal protective equipment should be donned and doffed in the presence of an assistant (ie, \"buddy\" system).","Cleve Clin J Med","Chahar, Praveen","Dugar, Sidharth","Marciniak, Donn","32414708"],"abstract":["Approximately 12% to 15% of hospitalized patients with COVID-19 infection require invasive ventilation via endotracheal intubation. The key to minimizing risk of disease transmission during this aerosol-generating procedure is careful preparation, which includes having necessary equipment and medications on hand as well as an experienced intubation team who can troubleshoot any unforeseen complications. Personal protective equipment should be donned and doffed in the presence of an assistant (ie, \"buddy\" system)."],"journal":"Cleve Clin J Med","authors":["Chahar, Praveen","Dugar, Sidharth","Marciniak, Donn"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414708","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3949/ccjm.87a.ccc033","topics":["Prevention"],"weight":1,"_version_":1666994545921884160,"score":9.490897,"similar":[{"pmid":32324365,"title":"[Airway management of coronavirus-infected patients].","text":["[Airway management of coronavirus-infected patients].","The coronavirus pandemic is a serious challenge for healthcare workers worldwide. The virus is spread through the air by droplets of moisture when people cough or sneeze and it has a very high virulence. Procedures generating airway aerosols are dangerous for every participant of patient care. The serious form of coronavirus infection can cause progressive respiratory failure. The best treatment is early endotracheal intubation and invasive mechanical ventilation. Intubation is an aerosol-generating process and thus carries the risk of contamination. Additionally the airway management of this patient population is usually difficult. The goal of this article is to give a practice-based overview of the peculiarities of airway management in coronavirus-infected patients with special regard to infection control and patient safety considerations. Orv Hetil. 2020; 161(17): 696-703.","Orv Hetil","Laszlo, Istvan","Molnar, Csilla","Koszta, Gyorgy","Vegh, Tamas","Fabian, Akos","Berhes, Mariann","Juhasz, Marianna","Fulesdi, Bela","32324365"],"abstract":["The coronavirus pandemic is a serious challenge for healthcare workers worldwide. The virus is spread through the air by droplets of moisture when people cough or sneeze and it has a very high virulence. Procedures generating airway aerosols are dangerous for every participant of patient care. The serious form of coronavirus infection can cause progressive respiratory failure. The best treatment is early endotracheal intubation and invasive mechanical ventilation. Intubation is an aerosol-generating process and thus carries the risk of contamination. Additionally the airway management of this patient population is usually difficult. The goal of this article is to give a practice-based overview of the peculiarities of airway management in coronavirus-infected patients with special regard to infection control and patient safety considerations. Orv Hetil. 2020; 161(17): 696-703."],"journal":"Orv Hetil","authors":["Laszlo, Istvan","Molnar, Csilla","Koszta, Gyorgy","Vegh, Tamas","Fabian, Akos","Berhes, Mariann","Juhasz, Marianna","Fulesdi, Bela"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324365","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1556/650.2020.31811","keywords":["ards","covid","rsi","airway management","betegbiztonsag","coronavirus","difficult airway","infection control","infekciokontroll","koronavirus","legzesi elegtelenseg","legutbiztositas","nehez legut","patient safety","respiratory insufficiency"],"topics":["Prevention"],"weight":1,"_version_":1666138493890330626,"score":157.62971},{"pmid":32502132,"title":"Airway management in the operating room and interventional suites in known or suspected COVID-19 adult patients: a practical review.","text":["Airway management in the operating room and interventional suites in known or suspected COVID-19 adult patients: a practical review.","Current evidence suggests that Coronavirus Disease 2019 (COVID-19) spread occurs via respiratory droplets (particles >5 microm), and possibly through aerosol. The rate of transmission remains high during airway management. This was evident during the 2003 severe acute respiratory syndrome epidemic where those who were involved in tracheal intubation had a higher risk of infection than those who were not involved (odds ratio 6.6). We describe specific airway management principles for patients with known or suspected COVID-19 disease for an array of critical care and procedural settings. We conducted a thorough search of the available literature of airway management of COVID-19 across a variety of international settings. In addition, we have analyzed various medical professional body recommendations for common procedural practices such as interventional cardiology, gastroenterology and pulmonology. A systematic process that aims to protect the operators involved via appropriate personal protective equipment, avoidance of unnecessary patient contact and minimalization of periprocedural aerosol generation are key components to successful airway management. For operating room cases requiring general anesthesia or complex interventional procedures, tracheal intubation should be the preferred option. For interventional procedures when tracheal intubation is not indicated, cautious conscious sedation appears to be a reasonable approach. Awake intubation should be avoided unless it is absolutely necessary. Extubation is a high-risk procedure for aerosol and droplet spread and needs thorough planning and preparation. As updates and modifications in the management of COVID-19 are still evolving, local guidelines, appraised at regular intervals, are vital in optimizing clinical management.","Anesth Analg","Thiruvenkatarajan, Venkatesan","Wong, David T","Kothandan, Harikrishnan","Sekhar, Vimal","Adhikary, Sanjib Das","Currie, John","Van Wijk, Roelof","32502132"],"abstract":["Current evidence suggests that Coronavirus Disease 2019 (COVID-19) spread occurs via respiratory droplets (particles >5 microm), and possibly through aerosol. The rate of transmission remains high during airway management. This was evident during the 2003 severe acute respiratory syndrome epidemic where those who were involved in tracheal intubation had a higher risk of infection than those who were not involved (odds ratio 6.6). We describe specific airway management principles for patients with known or suspected COVID-19 disease for an array of critical care and procedural settings. We conducted a thorough search of the available literature of airway management of COVID-19 across a variety of international settings. In addition, we have analyzed various medical professional body recommendations for common procedural practices such as interventional cardiology, gastroenterology and pulmonology. A systematic process that aims to protect the operators involved via appropriate personal protective equipment, avoidance of unnecessary patient contact and minimalization of periprocedural aerosol generation are key components to successful airway management. For operating room cases requiring general anesthesia or complex interventional procedures, tracheal intubation should be the preferred option. For interventional procedures when tracheal intubation is not indicated, cautious conscious sedation appears to be a reasonable approach. Awake intubation should be avoided unless it is absolutely necessary. Extubation is a high-risk procedure for aerosol and droplet spread and needs thorough planning and preparation. As updates and modifications in the management of COVID-19 are still evolving, local guidelines, appraised at regular intervals, are vital in optimizing clinical management."],"journal":"Anesth Analg","authors":["Thiruvenkatarajan, Venkatesan","Wong, David T","Kothandan, Harikrishnan","Sekhar, Vimal","Adhikary, Sanjib Das","Currie, John","Van Wijk, Roelof"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502132","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1213/ANE.0000000000005043","topics":["Prevention"],"weight":1,"_version_":1668804508758573056,"score":155.59515},{"pmid":32238613,"pmcid":"PMC7182733","title":"Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","text":["Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation areessential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19.","Indian Pediatr","Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan","32238613"],"abstract":["The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation areessential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19."],"journal":"Indian Pediatr","authors":["Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238613","source":"PubMed","week":"202014|Mar 30 - Apr 05","link_comment_for":"32238612","topics":["Prevention"],"weight":1,"_version_":1666138490308395008,"score":147.40443},{"pmid":32287142,"pmcid":"PMC7173403","title":"Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society.","text":["Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society.","The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has challenged medical systems and clinicians globally to unforeseen levels. COVID-19's rapid spread has forced clinicians to care for patients with a highly contagious disease without evidence-based guidelines. Using a virtual modified nominal group technique, the Pediatric Difficult Intubation Collaborative (PeDI-C), which currently includes 35 hospitals from six countries, generated consensus guidelines on airway management in pediatric anesthesia based on expert opinion and early data about the disease. The PeDI-C identified overarching goals during care, including minimizing aerosolized respiratory secretions, minimizing the number of clinicians in contact with a patient, and recognizing that undiagnosed asymptomatic patients may shed the virus and infect healthcare workers. Recommendations include administering anxiolytic medications, intravenous anesthetic inductions, tracheal intubation using video laryngoscopes and cuffed tracheal tubes, use of in-line suction catheters, and modifying workflow to recover patients from anesthesia in the operating room. Importantly, the PeDI-C recommends that anesthesiologists consider using appropriate personal protective equipment when performing aerosol-generating medical procedures in asymptomatic children, in addition to known or suspected children with COVID-19. Airway procedures should be done in negative pressure rooms when available. Adequate time should be allowed for operating room cleaning and air filtration between surgical cases. Research using rigorous study designs is urgently needed to inform safe practices during the COVID-19 pandemic. Until further information is available, the PeDI-C advises that clinicians consider these guidelines to enhance the safety of health care workers during airway management when performing aerosol-generating medical procedures. These guidelines have been endorsed by the Society for Pediatric Anesthesia and the Canadian Pediatric Anesthesia Society.","Anesth Analg","Matava, Clyde T","Kovatsis, Pete G","Summers, Jennifer Lee","Castro, Pilar","Denning, Simon","Yu, Julie","Lockman, Justin L","Von Ungern-Sternberg, Britta","Sabato, Stefano","Lee, Lisa K","Ayad, Ihab","Mireles, Sam","Lardner, David","Whyte, Simon","Szolnoki, Judit","Jagannathan, Narasimhan","Thompson, Nicole","Stein, Mary Lyn","Dalesio, Nicholas","Greenberg, Robert","McCloskey, John","Peyton, James","Evans, Faye","Haydar, Bishr","Reynolds, Paul","Chiao, Franklin","Taicher, Brad","Templeton, Thomas","Bhalla, Tarun","Raman, Vidya T","Garcia-Marcinkiewicz, Annery","Galvez, Jorge","Tan, Jonathan","Rehman, Mohamed","Crockett, Christy","Olomu, Patrick","Szmuk, Peter","Glover, Chris","Matuszczak, Maria","Galvez, Ignacio","Hunyady, Agnes","Polaner, David","Gooden, Cheryl","Hsu, Grace","Gumaney, Harshad","Perez-Pradilla, Caroline","Kiss, Edgar E","Theroux, Mary C","Lau, Jennifer","Asaf, Saeedah","Ingelmo, Pablo","Engelhardt, Thomas","Hervias, Monica","Greenwood, Eric","Javia, Luv","Disma, Nicola","Yaster, Myron","Fiadjoe, John E","32287142"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has challenged medical systems and clinicians globally to unforeseen levels. COVID-19's rapid spread has forced clinicians to care for patients with a highly contagious disease without evidence-based guidelines. Using a virtual modified nominal group technique, the Pediatric Difficult Intubation Collaborative (PeDI-C), which currently includes 35 hospitals from six countries, generated consensus guidelines on airway management in pediatric anesthesia based on expert opinion and early data about the disease. The PeDI-C identified overarching goals during care, including minimizing aerosolized respiratory secretions, minimizing the number of clinicians in contact with a patient, and recognizing that undiagnosed asymptomatic patients may shed the virus and infect healthcare workers. Recommendations include administering anxiolytic medications, intravenous anesthetic inductions, tracheal intubation using video laryngoscopes and cuffed tracheal tubes, use of in-line suction catheters, and modifying workflow to recover patients from anesthesia in the operating room. Importantly, the PeDI-C recommends that anesthesiologists consider using appropriate personal protective equipment when performing aerosol-generating medical procedures in asymptomatic children, in addition to known or suspected children with COVID-19. Airway procedures should be done in negative pressure rooms when available. Adequate time should be allowed for operating room cleaning and air filtration between surgical cases. Research using rigorous study designs is urgently needed to inform safe practices during the COVID-19 pandemic. Until further information is available, the PeDI-C advises that clinicians consider these guidelines to enhance the safety of health care workers during airway management when performing aerosol-generating medical procedures. These guidelines have been endorsed by the Society for Pediatric Anesthesia and the Canadian Pediatric Anesthesia Society."],"journal":"Anesth Analg","authors":["Matava, Clyde T","Kovatsis, Pete G","Summers, Jennifer Lee","Castro, Pilar","Denning, Simon","Yu, Julie","Lockman, Justin L","Von Ungern-Sternberg, Britta","Sabato, Stefano","Lee, Lisa K","Ayad, Ihab","Mireles, Sam","Lardner, David","Whyte, Simon","Szolnoki, Judit","Jagannathan, Narasimhan","Thompson, Nicole","Stein, Mary Lyn","Dalesio, Nicholas","Greenberg, Robert","McCloskey, John","Peyton, James","Evans, Faye","Haydar, Bishr","Reynolds, Paul","Chiao, Franklin","Taicher, Brad","Templeton, Thomas","Bhalla, Tarun","Raman, Vidya T","Garcia-Marcinkiewicz, Annery","Galvez, Jorge","Tan, Jonathan","Rehman, Mohamed","Crockett, Christy","Olomu, Patrick","Szmuk, Peter","Glover, Chris","Matuszczak, Maria","Galvez, Ignacio","Hunyady, Agnes","Polaner, David","Gooden, Cheryl","Hsu, Grace","Gumaney, Harshad","Perez-Pradilla, Caroline","Kiss, Edgar E","Theroux, Mary C","Lau, Jennifer","Asaf, Saeedah","Ingelmo, Pablo","Engelhardt, Thomas","Hervias, Monica","Greenwood, Eric","Javia, Luv","Disma, Nicola","Yaster, Myron","Fiadjoe, John E"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287142","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1213/ANE.0000000000004872","locations":["clinicians","anesthesia","anesthesia","Canadian"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1666138491390525440,"score":147.17848},{"pmid":32323287,"title":"[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].","text":["[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].","Against the background of the pandemic caused by infection with the SARS-CoV-2, the German Society for Pneumology and Respiratory Medicine (DGP e.V.), in cooperation with other associations, has designated a team of experts in order to answer the currently pressing questions about therapy strategies in dealing with COVID-19 patients suffering from acute respiratory insufficiency (ARI).The position paper is based on the current knowledge that is evolving daily. Many of the published and cited studies require further review, also because many of them did not undergo standard review processes.Therefore, this position paper is also subject to a continuous review process and will be further developed in cooperation with the other professional societies.This position paper is structured into the following five topics:1. Pathophysiology of acute respiratory insufficiency in patients without immunity infected with SARS-CoV-22. Temporal course and prognosis of acute respiratory insufficiency during the course of the disease3. Oxygen insufflation, high-flow oxygen, non-invasive ventilation and invasive ventilation with special consideration of infectious aerosol formation4. Non-invasive ventilation in ARI5. Supply continuum for the treatment of ARIKey points have been highlighted as core statements and significant observations. Regarding the pathophysiological aspects of acute respiratory insufficiency (ARI), the pulmonary infection with SARS-CoV-2 COVID-19 runs through three phases: early infection, pulmonary manifestation and severe hyperinflammatory phase.There are differences between advanced COVID-19-induced lung damage and those changes seen in Acute Respiratory Distress Syndromes (ARDS) as defined by the Berlin criteria. In a pathophysiologically plausible - but currently not yet histopathologically substantiated - model, two types (L-type and H-type) are distinguished, which correspond to an early and late phase. This distinction can be taken into consideration in the differential instrumentation in the therapy of ARI.The assessment of the extent of ARI should be carried out by an arterial or capillary blood gas analysis under room air conditions and must include the calculation of the oxygen supply (measured from the variables of oxygen saturation, the Hb value, the corrected values of the Hufner number and the cardiac output). In principle, aerosols can cause transmission of infectious viral particles. Open systems or leakage systems (so-called vented masks) can prevent the release of respirable particles. Procedures in which the invasive ventilation system must be opened, and endotracheal intubation must be carried out are associated with an increased risk of infection.The protection of personnel with personal protective equipment should have very high priority because fear of contagion must not be a primary reason for intubation. If the specifications for protective equipment (eye protection, FFP2 or FFP-3 mask, gown) are adhered to, inhalation therapy, nasal high-flow (NHF) therapy, CPAP therapy or NIV can be carried out according to the current state of knowledge without increased risk of infection to the staff. A significant proportion of patients with respiratory failure presents with relevant hypoxemia, often also caused by a high inspiratory oxygen fraction (FiO2) including NHF, and this hypoxemia cannot be not completely corrected. In this situation, CPAP/NIV therapy can be administered under use of a mouth and nose mask or a respiratory helmet as therapy escalation, as long as the criteria for endotracheal intubation are not fulfilled.In acute hypoxemic respiratory insufficiency, NIV should be performed in an intensive care unit or in a comparable unit by personnel with appropriate expertise. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring with readiness to carry out intubation must be ensured at all times. If CPAP/NIV leads to further progression of ARI, intubation and subsequent invasive ventilation should be carried out without delay if no DNI order is in place.In the case of patients in whom invasive ventilation, after exhausting all guideline-based measures, is not sufficient, extracorporeal membrane oxygenation procedure (ECMO) should be considered to ensure sufficient oxygen supply and to remove CO2.","Pneumologie","Pfeifer, M","Ewig, S","Voshaar, T","Randerath, W","Bauer, T","Geiseler, J","Dellweg, D","Westhoff, M","Windisch, W","Schonhofer, B","Kluge, S","Lepper, P M","32323287"],"journal":"Pneumologie","authors":["Pfeifer, M","Ewig, S","Voshaar, T","Randerath, W","Bauer, T","Geiseler, J","Dellweg, D","Westhoff, M","Windisch, W","Schonhofer, B","Kluge, S","Lepper, P M"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323287","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1055/a-1157-9976","locations":["Berlin"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Treatment","Prevention"],"weight":1,"abstract":["Against the background of the pandemic caused by infection with the SARS-CoV-2, the German Society for Pneumology and Respiratory Medicine (DGP e.V.), in cooperation with other associations, has designated a team of experts in order to answer the currently pressing questions about therapy strategies in dealing with COVID-19 patients suffering from acute respiratory insufficiency (ARI).The position paper is based on the current knowledge that is evolving daily. Many of the published and cited studies require further review, also because many of them did not undergo standard review processes.Therefore, this position paper is also subject to a continuous review process and will be further developed in cooperation with the other professional societies.This position paper is structured into the following five topics:1. Pathophysiology of acute respiratory insufficiency in patients without immunity infected with SARS-CoV-22. Temporal course and prognosis of acute respiratory insufficiency during the course of the disease3. Oxygen insufflation, high-flow oxygen, non-invasive ventilation and invasive ventilation with special consideration of infectious aerosol formation4. Non-invasive ventilation in ARI5. Supply continuum for the treatment of ARIKey points have been highlighted as core statements and significant observations. Regarding the pathophysiological aspects of acute respiratory insufficiency (ARI), the pulmonary infection with SARS-CoV-2 COVID-19 runs through three phases: early infection, pulmonary manifestation and severe hyperinflammatory phase.There are differences between advanced COVID-19-induced lung damage and those changes seen in Acute Respiratory Distress Syndromes (ARDS) as defined by the Berlin criteria. In a pathophysiologically plausible - but currently not yet histopathologically substantiated - model, two types (L-type and H-type) are distinguished, which correspond to an early and late phase. This distinction can be taken into consideration in the differential instrumentation in the therapy of ARI.The assessment of the extent of ARI should be carried out by an arterial or capillary blood gas analysis under room air conditions and must include the calculation of the oxygen supply (measured from the variables of oxygen saturation, the Hb value, the corrected values of the Hufner number and the cardiac output). In principle, aerosols can cause transmission of infectious viral particles. Open systems or leakage systems (so-called vented masks) can prevent the release of respirable particles. Procedures in which the invasive ventilation system must be opened, and endotracheal intubation must be carried out are associated with an increased risk of infection.The protection of personnel with personal protective equipment should have very high priority because fear of contagion must not be a primary reason for intubation. If the specifications for protective equipment (eye protection, FFP2 or FFP-3 mask, gown) are adhered to, inhalation therapy, nasal high-flow (NHF) therapy, CPAP therapy or NIV can be carried out according to the current state of knowledge without increased risk of infection to the staff. A significant proportion of patients with respiratory failure presents with relevant hypoxemia, often also caused by a high inspiratory oxygen fraction (FiO2) including NHF, and this hypoxemia cannot be not completely corrected. In this situation, CPAP/NIV therapy can be administered under use of a mouth and nose mask or a respiratory helmet as therapy escalation, as long as the criteria for endotracheal intubation are not fulfilled.In acute hypoxemic respiratory insufficiency, NIV should be performed in an intensive care unit or in a comparable unit by personnel with appropriate expertise. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring with readiness to carry out intubation must be ensured at all times. If CPAP/NIV leads to further progression of ARI, intubation and subsequent invasive ventilation should be carried out without delay if no DNI order is in place.In the case of patients in whom invasive ventilation, after exhausting all guideline-based measures, is not sufficient, extracorporeal membrane oxygenation procedure (ECMO) should be considered to ensure sufficient oxygen supply and to remove CO2."],"_version_":1666138493893476353,"score":138.14857}]}